Drug data last refreshed 23h ago · AI intelligence enriched 1w ago
IMODIUM is an oral solution small-molecule antidiarrheal agent approved in 1984. The drug treats acute and chronic diarrhea across multiple etiologies. It works by reducing intestinal motility and fluid secretion, providing symptomatic relief.
As LOE approaches, commercial teams are shifting focus to defending market share against generics and generic erosion models; team size likely stabilizing or consolidating.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
A Study of Combination Caplet With Loperamide Hydrochloride and Simethicone, and Imodium Express Tablets-lyophilizate Coadministered With Espumisan Capsule in Healthy Volunteers
Working on IMODIUM offers stable, hands-on commercial experience in a mature, established brand within J&J's consumer health portfolio. Career growth is incremental; positions emphasize defensive marketing, generic competition navigation, and OTC channel management rather than innovation.
Worked on IMODIUM at Johnson & Johnson? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.